The TRIMEDX CYBER Advanced offering, in partnership with Medigate, an industry leading IoMT provider, delivers deep integration and live, dynamic collection of data on each of your connected medical devices. This data collection includes: • Known clinical assets connected to the network • Additional connected clinical assets identified through MDSP technology • Connected clinical assets added to network on an ongoing basis • Percentage completeness of the collection of critical data points for clinical assets Our dedicated CYBER Specialists monitor 40+ intelligence sources to identify vulnerabilities, advocate with OEMs to acquire OEM-validated patches, apply appropriate patches or compensating controls if no patch is available and fully track all remediation efforts. Through the ongoing visibility provided by this process, clients have access to the comprehensive TRIMEDX CYBER Risk Score, real-time cyber alerting capabilities and greater inventory accuracy, allowing for a more accurate understanding of your cybersecurity risk, while enabling faster identification/location of equipment in the event of a cybersecurity threat.

As the largest independent, technology-enabled clinical asset management company in the United States, TRIMEDX provides strategic planning and management of clinical assets to drive operational cost savings, free up capital for new strategic initiatives and deliver improved risk management and cyber protection.

Invaryant connects to all leading EMR/EHR systems, wearables, internet of medical things, and telehealth and remote monitoring. With patient permission, retrieve your patients' health and medical information wherever it exists (e.g., different EMR systems).

Invaryant is a Georgia-based health tech company enabling safer healthcare through integrated, real-world data and patented technologies. Our platform connects patients with those who make healthy possible, creating a secure, real-time, inter- & extraoperable environment for patient safety. Who benefits from Invaryant? • Patients • Physicians and other providers (in-person and telehealth) • Researchers • Patient safety programs (such as REMS and pharmacovigilance)